Eric S. Muise
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI(2008)1,018 cited
- → Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice(1997)358 cited
- → PD-1hiCXCR5– T peripheral helper cells promote B cell responses in lupus via MAF and IL-21(2019)301 cited
- → Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic States(2008)298 cited
- → SirT1 Regulates Adipose Tissue Inflammation(2011)282 cited
- → Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo(2009)145 cited
- → Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy(2020)108 cited
- → Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene(2019)89 cited
- → Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey(2001)79 cited
- → ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells(2020)72 cited